5 New Holdings Added to STI Equity Trades Portfolio

As explained in this week’s edition of Smart Tech 50 Weekly Movers, we are adding the following holdings to the STI Equity Trades Portfolio:
STOCK
Repligen (RGEN)
Emergent BioSolutions (EBS)
Medivation (MDVN)
ETF
iShares Nasdaq Biotechnology ETF (IBB)
PowerShares Dynamic Biotech & Genome ETF (PBE)

Stock Talk

Lucille Layne

Lucille Layne

RGEN sounds interesting. I’m wondering how much of a risk factor does it have. Also I just subscribed to SmartTech. One reason I decided to start this was to gain the title of the company of the little $7.00 stock you kept talking about & pushing. As yet I have not received it. I would appreciate it ASAP. I have been a member of Personal Finance for several years & look forward to hearing information now in Smart Tech. Thank you.

Jim Pearce

Jim Pearce

Lucille,

The stock in question is Lattice Semiconductor (LSCC), which is in our Equity Trades portfolio. I’m wondering if perhaps your email spam filter may have blocked our message (since it includes an attachment), so could you check that for me and let me know if it is there? Thank you.

Jim

Guest User

Guest User

Any insight as to why LSCC is now below the stop price identified herein other than China demand?
Would you recommend selling or holding below the stop price?
Thanks

Jim Pearce

Jim Pearce

Due to the unusual nature of China’s stock market volatility I have temporarily reduced the stop price on LSCC to allow time for that situation to work its way out, so I’d hold on to it for the time being. The company announces quarterly earnings later this week, which is presumably one of the reasons why its share price has been dropping. But if it closes below $4.50 after announcing earnings, I will reevaluate the situation. Thank you.

Lucille Layne

Lucille Layne

It is corrected now. Thank you. LL

Guest One

Joe Duarte

EBIS Portfolio holding Masimo (MASI) beat earnings handily. Now waiting for others to report this week.

Guest One

Joe Duarte

EBIS Portfolio updates:

Repligen (RGEN) and Emergent Biosolutions (EBS) both reported earnings before the market opened this morning. Results were generally positive. RGEN upped its guidance.

Add New Comments

You must be logged in to post to Stock Talk OR create an account